Curis CRIS
NASDAQ CRIS
$1.20 -0.07 (-5.51%)
At close: Sep 9, 2026 · 4:00 PM EDT

Curis (CRIS) EV to EBIT (2010 - 2026)

Curis' (CRIS) quarterly EV to EBIT came in at 0.46 in Q2 2026, down 57.04% on a YoY basis from 1.08 in Q2 2025, and down 63.13% quarter-over-quarter from 1.26 in Q1 2026.

Analysis

Curis (CRIS) EV to EBIT (2010 - 2026) Analysis & Trends

Curis (CRIS) has reported EV to EBIT for 17 consecutive years, with 0.46 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, EV to EBIT fell 57.04% year-over-year to 0.46; the trailing twelve-month figure through Jun 2026 stood at 0.53 (up 124.2% YoY), and the FY2025 full-year result was 0.77, up 81.19% from the prior year.
  • EV to EBIT fell to 0.46 in Q2 2026 per CRIS's latest filing, from 1.26 in the prior quarter.
  • Across five years, EV to EBIT topped out at 8.12 in Q4 2022 and bottomed at 0.23 in Q4 2025.
  • Historically, EV to EBIT has averaged 3.61 across 5 years, with a median of 2.56 in 2024.
  • The sharpest annual moves came in 2022 and 2025: EV to EBIT grew 8.45% in 2022, then slumped 110.65% in 2025.
  • Over 5 years, EV to EBIT stood at 8.12 in 2022, then plunged by 46.91% to 4.31 in 2023, then tumbled by 50.9% to 2.12 in 2024, then plunged by 110.65% to 0.23 in 2025, then surged by 305.43% to 0.46 in 2026.
  • According to Business Quant data, EV to EBIT over the past three periods registered 0.46, 1.26, and 0.23 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Curis 2.63 Mn -2.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.46
Mar 31, 2026 1.26
Dec 31, 2025 -0.23
Sep 30, 2025 1.15
Jun 30, 2025 1.08
Mar 31, 2025 1.91
Dec 31, 2024 2.12
Sep 30, 2024 1.82
Jun 30, 2024 2.10
Mar 31, 2024 3.01
Dec 31, 2023 4.31
Sep 30, 2023 5.38
Jun 30, 2023 4.89
Mar 31, 2023 5.92
Dec 31, 2022 8.12
Sep 30, 2022 7.56
Jun 30, 2022 6.82
Mar 31, 2022 7.25
Dec 31, 2021 7.49
Sep 30, 2021 9.26